Rheum. 2010; 62(8): 2467-75.
40. Hu J, Yu X, Wang Z, et al. Long term effects of the implantation of
Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for
newly-onset type 1 diabetes mellitus. Endocr J. 2013; 60(3): 347-57.
41. Connick P, Kolappan M, Crawley C, et al. Autologous mesenchymal
stem cells for the treatment of secondary progressive multiple sclerosis: an open-
label phase 2a proof-of-concept study. Lancet Neurol. 2012; 11(2): 150-6.
42. Gupta PK, Das AK, Chullikana A, Majumdar AS, et al. Mesenchymal
stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther. 2012; 3(4):
25.
43. Arufe MC, De la Fuente A, Fuentes I, De Toro FJ, Blanco FJ, et al.
Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.
World J Orthop. 2011; 2(6): 43-50.
44. Zhou B, Yuan J, Zhou Y, et al, Administering human adipose-derived
mesenchymal stem cells to prevent and treat experimental arthritis. Clin
Immunol. 2011; 141(3): 328-37.
45. Park MJ, Park HS, Cho ML, et al. Transforming growth factor beta-
transduced mesenchymal stem cells ameliorate experimental autoimmune
arthritis through reciprocal regulation of Treg/T17 cells and osteoclastogenesis.
Arthritis Rheum. 2011; 63(6): 1668-80.
46. González MA, Gonzalez-Rey E, Rico L, et al. Treatment of experimental
arthritis by inducing immune tolerance with human adipose-derived
mesenchymal stem cells. Arthritis Rheum. 2009; 60(4): 1006-19.
47. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G, et al. Cell
therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue
damage in collagen-induced arthritis. Arthritis Rheum. 2007; 56(4): 1175-86.
48. Wang Q, Li X, Luo J, et al. The allogeneic umbilical cord mesenchymal
stem cells regulate the function of T helper 17 cells from patients with
rheumatoid arthritis in an in vitro co-culture system. BMC Musculoskelet Disord.
2012; 13: 249.
